<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00284609</url>
  </required_header>
  <id_info>
    <org_study_id>(KF) 01 287360</org_study_id>
    <secondary_id>2005-41-6000</secondary_id>
    <secondary_id>MPU 39-2005</secondary_id>
    <nct_id>NCT00284609</nct_id>
  </id_info>
  <brief_title>Rehabilitation of Type 2 Diabetes Patients.</brief_title>
  <official_title>&quot;The Effect of Rehabilitation of Type 2 Diabetes Mellitus Versus Standard Outpatient Care.&quot; A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Board of Health, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Health and Care Committee, Copenhagen City Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the effect of a new rehabilitation program of type 2
      diabetes patients in a primary care center versus standard care in the outpatient Hospital
      Clinic.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Type 2 diabetes is major and growing health care problem and is associated with premature
      mortality and increased morbidity. At the time of diagnosis half of the patients have
      cardiovascular, renal, ophthalmic or neurological disease. A recent Danish intervention study
      found a marked reduction in cardiovascular events and microvascular complications in a group
      of patients with type 2 diabetes and microalbuminuria using an intensive multifactorial
      pharmacologic intervention and lifestyle intervention (3). The achieved changes in lifestyle
      seems however to vanish after a short period. Lack of information, unawareness of the
      seriousness of the disease and lack of supervised training and insufficient follow-up may be
      of importance of the long-term outcome in these patients.

      A total number of 180 patients with type 2 diabetes, will be randomized to the intervention
      group or to standard care.

      This study tests an intensive intervention of lifestyle by a newly developed program of
      rehabilitation compared with routine standards in a randomized controlled design. Provided
      that a significant positive outcome is found, the non-pharmacologic treatment of type 2
      diabetes could be optimized and inpatient hospitalization due to complications could be
      avoided.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in HgbA1c (Glycemic control)</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>fasting total cholesterol, triglycerides, HDL and LDL,</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood pressure,</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>weight,</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>waist circumference,</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fitness test,</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>muscle strength test,</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>occurrence of complications,</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inflammatory markers,</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>beta-cell function test (HOMA-test),</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>endothelia cell markers,</measure>
    <time_frame>Not yet known</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>use of medication</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost-benefit.</measure>
    <time_frame>Not yet known</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>baseline, six month, one year, two years and three years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Group based non-pharmacological rehabilitation</intervention_name>
    <description>6 x 1.5 hours education program in group classes taught by nurse, physiotherapist, dietitian and chiropodist.
24 x 1.5 hours training program (both aerobic and anaerobic exercise) in group classes supervised by a physiotherapist.
3 x 3 hours cooking sessions in group classes supervised by a dietitian.
Intervention period: 6 month</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Individual non-pharmacological rehabilitation</intervention_name>
    <description>Individual counseling in Outpatient Clinic, including patient education, physical activity and diet instruction.
4 x 1 hour with a diabetes nurse,
3 x 0.5 hour with a dietitian and
1 hour with a chiropodist.
Intervention period: 6 month</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of Type 2 diabetes mellitus

          -  HgbA1c between 6,8 - 10,0%

          -  With or without one or more micro- and macrovascular or neurological complications.

        Exclusion Criteria:

          -  HgbA1c &lt; 6,8 and &gt; 10,0 %

          -  Patients who have attended lifestyle intervention in the past year

          -  Patients who is planned to start treatment with insulin during intervention period

          -  Lack of motivation

          -  Patients with severe heart-, liver or kidney disease or incurable cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva S Vadstrup, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Endocrine Section, Dept Internal Medicine I, Bispebjerg Hospital, University of Copenhagen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Røder, DMSc</last_name>
    <role>Study Director</role>
    <affiliation>Endocrine Section, Dept Internal Medicine I, Bispebjerg Hospital, University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Endocrine Section, Dept Internal Medicine I, Bispebjerg Hospital, University of Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <state>Copenhagen NV</state>
        <zip>DK-2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003 Jan 30;348(5):383-93.</citation>
    <PMID>12556541</PMID>
  </reference>
  <reference>
    <citation>Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998 Sep 12;352(9131):837-53. Erratum in: Lancet 1999 Aug 14;354(9178):602.</citation>
    <PMID>9742976</PMID>
  </reference>
  <reference>
    <citation>Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA. 2001 Sep 12;286(10):1218-27. Review.</citation>
    <PMID>11559268</PMID>
  </reference>
  <reference>
    <citation>Boulé NG, Kenny GP, Haddad E, Wells GA, Sigal RJ. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia. 2003 Aug;46(8):1071-81. Epub 2003 Jul 10.</citation>
    <PMID>12856082</PMID>
  </reference>
  <reference>
    <citation>Krotkiewski M, Lönnroth P, Mandroukas K, Wroblewski Z, Rebuffé-Scrive M, Holm G, Smith U, Björntorp P. The effects of physical training on insulin secretion and effectiveness and on glucose metabolism in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1985 Dec;28(12):881-90.</citation>
    <PMID>3912243</PMID>
  </reference>
  <reference>
    <citation>Yeater RA, Ullrich IH, Maxwell LP, Goetsch VL. Coronary risk factors in type II diabetes: response to low-intensity aerobic exercise. W V Med J. 1990 Jul;86(7):287-90.</citation>
    <PMID>2368376</PMID>
  </reference>
  <reference>
    <citation>Wing RR. Physical activity in the treatment of the adulthood overweight and obesity: current evidence and research issues. Med Sci Sports Exerc. 1999 Nov;31(11 Suppl):S547-52.</citation>
    <PMID>10593526</PMID>
  </reference>
  <reference>
    <citation>Renders CM, Valk GD, Griffin SJ, Wagner EH, Eijk Van JT, Assendelft WJ. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care. 2001 Oct;24(10):1821-33. Review.</citation>
    <PMID>11574449</PMID>
  </reference>
  <reference>
    <citation>Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care. 2002 Jul;25(7):1159-71.</citation>
    <PMID>12087014</PMID>
  </reference>
  <reference>
    <citation>GESICA Investigators. Randomised trial of telephone intervention in chronic heart failure: DIAL trial. BMJ. 2005 Aug 20;331(7514):425.</citation>
    <PMID>16061499</PMID>
  </reference>
  <reference>
    <citation>Han TS, van Leer EM, Seidell JC, Lean ME. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995 Nov 25;311(7017):1401-5.</citation>
    <PMID>8520275</PMID>
  </reference>
  <reference>
    <citation>Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willett WC, Manson JE. Abdominal adiposity and coronary heart disease in women. JAMA. 1998 Dec 2;280(21):1843-8.</citation>
    <PMID>9846779</PMID>
  </reference>
  <reference>
    <citation>Lakka HM, Lakka TA, Tuomilehto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J. 2002 May;23(9):706-13.</citation>
    <PMID>11977996</PMID>
  </reference>
  <reference>
    <citation>Bigaard J, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL, Sørensen TI. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res. 2003 Jul;11(7):895-903.</citation>
    <PMID>12855760</PMID>
  </reference>
  <reference>
    <citation>Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1384-7.</citation>
    <PMID>9817683</PMID>
  </reference>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2006</study_first_submitted>
  <study_first_submitted_qc>January 31, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2006</study_first_posted>
  <last_update_submitted>March 25, 2010</last_update_submitted>
  <last_update_submitted_qc>March 25, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2010</last_update_posted>
  <responsible_party>
    <name_title>Michael Røder</name_title>
    <organization>Bispebjerg Hospital</organization>
  </responsible_party>
  <keyword>Type 2 diabetes,</keyword>
  <keyword>rehabilitation,</keyword>
  <keyword>quality of life,</keyword>
  <keyword>glycaemic control,</keyword>
  <keyword>lifestyle intervention,</keyword>
  <keyword>patient education,</keyword>
  <keyword>physical training,</keyword>
  <keyword>group visits,</keyword>
  <keyword>reminders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

